Clinical Trial Update: Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating high-dose intravenous proton pump inhibitor before endoscopy in peptic ulcer-related upper gastrointestinal bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer

Drugs mentioned

• Proton pump inhibitor (intravenous) (proton pump inhibitor)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Peptic Ulcer | Phase 4 | Status: COMPLETED